See Shionogi-Sponsored Publications

Publications

Here, you can review available Shionogi-sponsored publications. If you would like an electronic copy of one of the journal publications on this page, please contact
Shionogi Medical Information for further assistance.

Looking for a specific publication? Use the Search feature above to find content by keyword, author, title, disease state, medicine, or compound. Please note that Search functions site-wide and will take you to a separate results page.

Information about investigational compounds or investigational uses of products does not imply FDA approval of these compounds or uses, nor does it establish the safety or efficacy of these compounds or uses. There is no guarantee that the investigational compounds or investigational uses of products will receive FDA approval. Shionogi does not recommend or suggest use of its products in a manner inconsistent with FDA-approved labeling.

  • All
  • Cefiderocol
  • Edaravone
  • Ensitrelvir
  • Zatolmilast
  • All
  • In vitro
  • Preclinical
  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • Real-world evidence
  • Surveillance
  • Review
  • Pharmacokinetics/Pharmaco-dynamics
  • Compatibility
  • All
  • Amyotrophic Lateral Sclerosis (ALS)
  • COVID-19
  • Fragile X syndrome
  • Gram-negative infection
 
Ensitrelvir
Pharmacokinetics/Pharmacodynamics
COVID-19

Effects of ensitrelvir on the pharmacokinetics of combined oral contraceptives (ethinyl estradiol/drospirenone) in healthy adult women: a phase 1 fixed-sequence, multiple-dose, drug–drug interaction study

Published:
2026
Authors:
Shimizu R, Shibata RY, Kubota R, et al.
View Publication
 
Ensitrelvir
Phase 3
COVID-19

Ensitrelvir for COVID-19 postexposure prophylaxis in household contacts 

Published:
2026
Authors:
Hayden FG, Shinkai M, Clark TW, et al.
View Publication
 
Ensitrelvir
Real-world evidence
Surveillance
COVID-19

Ensitrelvir for the treatment of COVID-19: Final analysis of a post-marketing surveillance from Japan

Published:
2025
Authors:
Hayashi N, Tsukimura E, Ogura E
View Publication
 
Ensitrelvir
Phase 3
COVID-19

Ensitrelvir for the treatment of nonhospitalized adults with COVID-19: Results from the SCORPIO-HR, phase 3, randomized, double-blind, placebo-controlled trial

Published:
2025
Authors:
Luetkemeyer AF, Chew KW, Lacey S, et al.
View Publication
 
Ensitrelvir
Real-world evidence
COVID-19

Ensitrelvir in hospitalized patients with SARS-CoV-2 during the Omicron epidemic: A single-center observational study

Published:
2025
Authors:
Yamato M, Kinoshita M, Yoshida Y, et al.
View Publication